• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖和高血压对限制静脉血容量具有累加效应。

Additive effects of obesity and hypertension to limit venous volume.

作者信息

Stepniakowski K, Egan B M

机构信息

Department of Pharmacology, Medical University of South Carolina, Charleston 29425-2251.

出版信息

Am J Physiol. 1995 Feb;268(2 Pt 2):R562-8. doi: 10.1152/ajpregu.1995.268.2.R562.

DOI:10.1152/ajpregu.1995.268.2.R562
PMID:7864253
Abstract

The presence of reduced venous distensibility in obesity might have important hemodynamic effects and could indirectly implicate a role for metabolic factors in vascular control, because loading conditions are different in arterial and in venous vessels. Forearm blood flow and venous volume were measured plethysmographically in 58 subjects, including lean and obese hypertensives and normotensives. Venous volume at 30 mmHg (VV30) was decreased by both obesity and hypertension. This coincided with evidence for better preservation of central blood and stroke volumes with upright posture in obese than in lean subjects. Furthermore, obese hypertensives had lower VV30 than either lean hypertensives or obese normotensives. Postischemic forearm vascular resistance, a surrogate marker for structural luminal cross-sectional area, percent body fat, and fasting insulin each correlated independently with VV30 (P < 0.05) in multivariate analysis. Because nonesterified fatty acid levels are elevated in obese hypertensives and may have potent vascular effects, dorsal hand vein responses to coinfusion of Intralipid 10% and heparin to raise fatty acids locally were obtained in normal volunteers. The local infusion of Intralipid with heparin reduced hand vein distensibility, whereas dextrose and heparin did not (11 +/- 3% vs. 0 +/- 2%, respectively, P < 0.01). This study indicates that obesity and mild hypertension each reduce venous distensibility and that the coexistence of both conditions produces an even greater impairment in venous capacitance. The reduced venous distensibility in obesity appears to reflect structural as well as functional factors and to have systemic hemodynamic effects.

摘要

肥胖患者静脉扩张性降低可能具有重要的血液动力学影响,并可能间接暗示代谢因素在血管控制中的作用,因为动脉和静脉血管的负荷条件不同。采用体积描记法测量了58名受试者的前臂血流量和静脉容量,包括瘦型和肥胖型高血压患者以及血压正常者。肥胖和高血压均导致30 mmHg时的静脉容量(VV30)降低。这与肥胖受试者比瘦型受试者在直立姿势下能更好地保存中心血量和每搏输出量的证据相一致。此外,肥胖型高血压患者的VV30低于瘦型高血压患者或肥胖型血压正常者。在多变量分析中,缺血后前臂血管阻力、结构管腔横截面积的替代指标、体脂百分比和空腹胰岛素水平均与VV30独立相关(P<0.05)。由于肥胖型高血压患者的非酯化脂肪酸水平升高且可能具有强大的血管效应,因此在正常志愿者中获得了手背静脉对同时输注10%脂肪乳和肝素以局部升高脂肪酸的反应。脂肪乳与肝素的局部输注降低了手静脉的扩张性,而葡萄糖和肝素则没有(分别为11±3%和0±2%,P<0.01)。这项研究表明,肥胖和轻度高血压均会降低静脉扩张性,且两种情况并存会使静脉容量受损更严重。肥胖患者静脉扩张性降低似乎反映了结构和功能因素,并具有全身血液动力学效应。

相似文献

1
Additive effects of obesity and hypertension to limit venous volume.肥胖和高血压对限制静脉血容量具有累加效应。
Am J Physiol. 1995 Feb;268(2 Pt 2):R562-8. doi: 10.1152/ajpregu.1995.268.2.R562.
2
[Regional hemodynamics of the forearm. Comparison between obese and non-obese hypertensive patients].[前臂的区域血流动力学。肥胖与非肥胖高血压患者的比较]
Arch Mal Coeur Vaiss. 1988 Jun;81 Spec No:65-9.
3
Insulin increases forearm vascular resistance in obese, insulin-resistant hypertensives.胰岛素会增加肥胖、胰岛素抵抗型高血压患者的前臂血管阻力。
J Hypertens. 1996 Jan;14(1):91-7.
4
Decreased venous distensibility in essential hypertension: lack of systemic hemodynamic correlates.原发性高血压患者静脉扩张性降低:缺乏全身血流动力学相关性。
Angiology. 1979 Mar;30(3):147-59. doi: 10.1177/000331977903000301.
5
Pattern of peripheral venous response to volume expansion in borderline systemic hypertension.临界系统性高血压患者外周静脉对容量扩张的反应模式
Am J Cardiol. 1990 Sep 1;66(5):597-602. doi: 10.1016/0002-9149(90)90487-l.
6
Forearm haemodynamics in obese normotensive and hypertensive subjects.肥胖正常血压和高血压受试者的前臂血流动力学
J Hypertens. 1988 Apr;6(4):299-303.
7
[Venous distensibility in essential hypertension].[原发性高血压中的静脉扩张性]
Kardiologiia. 1985 Jan;25(1):54-7.
8
Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function.中心性肥胖与高血压:肾血流动力学和功能的病理生理作用
Int J Obes Relat Metab Disord. 1995 Jun;19(6):403-9.
9
Compensatory hyperinsulinemia and the forearm vasodilator response during an oral glucose-tolerance test in obese hypertensives.肥胖高血压患者口服葡萄糖耐量试验期间的代偿性高胰岛素血症及前臂血管舒张反应
J Hypertens. 1994 Sep;12(9):1061-7.
10
The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human subjects.吗啡对心血管系统的影响。人体受试者的外周容量血管和阻力血管。
J Clin Invest. 1974 Dec;54(6):1247-58. doi: 10.1172/JCI107869.

引用本文的文献

1
The Effect of Intermittent Pneumatic Compression on Hemodynamics and Regional Cerebral Oxygen Saturation in Laparoscopic Bariatric Surgery with Mild Hypercapnia in the Steep Reverse Trendelenburg Position.间歇性气动压迫对处于陡峭反向头低脚高位且伴有轻度高碳酸血症的腹腔镜减肥手术中血流动力学及局部脑氧饱和度的影响
J Pers Med. 2024 Apr 11;14(4):405. doi: 10.3390/jpm14040405.
2
The Role of the Vasculature in Heart Failure.血管系统在心力衰竭中的作用。
Curr Heart Fail Rep. 2023 Jun;20(3):179-190. doi: 10.1007/s11897-023-00602-4. Epub 2023 May 9.
3
Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
理解左心疾病所致肺动脉高压的病理生理学。
Circ Res. 2022 Apr 29;130(9):1382-1403. doi: 10.1161/CIRCRESAHA.122.319967. Epub 2022 Apr 28.
4
Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease.心力衰竭射血分数保留型的炎症代谢表型特征:一种解释性别对疾病演变和潜在治疗影响的假说。
Eur J Heart Fail. 2020 Sep;22(9):1551-1567. doi: 10.1002/ejhf.1902. Epub 2020 Jun 26.
5
Cardiac function and arteriovenous oxygen difference during exercise in obese adults.肥胖成年人运动时的心脏功能和动静脉血氧差。
Eur J Appl Physiol. 2011 Jun;111(6):915-23. doi: 10.1007/s00421-010-1554-z. Epub 2010 Nov 11.
6
Impaired in vivo venous constriction in conscious obese Zucker rats with metabolic syndrome.患有代谢综合征的清醒肥胖 Zucker 大鼠体内静脉收缩功能受损。
Naunyn Schmiedebergs Arch Pharmacol. 2006 Sep;373(6):451-6. doi: 10.1007/s00210-006-0088-8. Epub 2006 Aug 31.